Myeloablative therapy

Neuroblastoma

Neuroblastoma
Neuroblastoma is the most common extracranial solid cancer in childhood and the most common cancer in infancy, with an annual incidence of about 650 new cases per year in the US. Close to 50 percent of neuroblastoma cases occur in children younger than two years old. It is a neuroendocrine tumor, arising from any neural crest element of the sympathetic nervous system or SNS. It most frequently originates in one of the adrenal glands, but can also develop in nerve tissues in the neck, chest, abdomen, or pelvis. Neuroblastoma is one of the few human malignancies known to demonstrate spontaneous regression from an undifferentiated state to a completely benign cellular appearance...

Myeloablative therapy - List of case studies

IgG Multiple Myeloma

followed by thalidomide. The disease has responded to therapy. questions:  ... donor. There are two types of allogeneic HSCT – myeloablative and reduced intensity. Since the patient has already had an ...

Stage 4 Neuroblastoma

Vincristine and Etoposide has been administered. The therapy has been, on the whole, well tolerated.” June, 2009 : ... high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology ...

JustAnswer.com